Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Nanjing
Clinical trial register · China

Clinical Trials in Nanjing, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19224 matching records held by the registry are in this view. Synced 11 Nov 2026, 03:17 UTC
19224
Studies in scope
all four open statuses
11811
Recruiting now
open to new participants
2030
Lead sponsors
across recruiting studies
Top sites
Beijing 1 Wuhan 1 Nanjing 1 Dalian 1 Jinan 1
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
The First Affiliated Hospital with Nanjing Medical University203 The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School87 Nanjing First Hospital, Nanjing Medical University72 Nanjing Medical University30 The Second Hospital of Nanjing Medical University30 AstraZeneca27 Zhongda Hospital27 Novartis Pharmaceuticals27 Jinling Hospital, China24 Southeast University, China22 Jiangsu Cancer Institute & Hospital17 Janssen Research & Development, LLC16 Pfizer15 Bristol-Myers Squibb12 Hoffmann-La Roche12 AbbVie11 Merck Sharp & Dohme LLC10 Eli Lilly and Company10 GlaxoSmithKline9 Jiangsu Province Nanjing Brain Hospital8 Boehringer Ingelheim8 Chia Tai Tianqing Pharmaceutical Group Co., Ltd.8 Changchun GeneScience Pharmaceutical Co., Ltd.7 BeOne Medicines6 Nanjing Children's Hospital6 Sun Yat-sen University6 Jiangsu HengRui Medicine Co., Ltd.6 Shao Pengfei6 Jiangsu Simcere Pharmaceutical Co., Ltd.5 Shandong Suncadia Medicine Co., Ltd.5 Shanghai Zhongshan Hospital5 Peking Union Medical College Hospital5 Sanofi5 Chongqing Precision Biotech Co., Ltd4 Fujian Shengdi Pharmaceutical Co., Ltd.4 CSPC Ouyi Pharmaceutical Co., Ltd.4 Nanjing University School of Medicine4 Jiangsu Famous Medical Technology Co., Ltd.4 Dizal Pharmaceuticals4 Cancer Institute and Hospital, Chinese Academy of Medical Sciences4 Amgen4 TransThera Sciences (Nanjing), Inc.4 baotai Liang4 Jiangsu vcare pharmaceutical technology co., LTD4 Novo Nordisk A/S4 RenJi Hospital4 Daiichi Sankyo4 Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.4 Haisco Pharmaceutical Group Co., Ltd.4 Karuna Therapeutics, Inc., a Bristol Myers Squibb company3 Suzhou Suncadia Biopharmaceuticals Co., Ltd.3 China National Center for Cardiovascular Diseases3 InxMed (Shanghai) Co., Ltd.3 Nanjing University of Traditional Chinese Medicine3 First Affiliated Hospital of Zhejiang University3 Huashan Hospital3 Faming Zhang3 Qilu Pharmaceutical Co., Ltd.3 Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.3 Institute of Hematology & Blood Diseases Hospital, China3 Peking Union Medical College3 Nanjing University3 Bayer3 RemeGen Co., Ltd.3 Celgene3 Peking University First Hospital3 Lanyue Zhu3 Changzhou No.2 People's Hospital3 Shanghai Chest Hospital3 Nanjing IASO Biotechnology Co., Ltd.3 Nanjing Leads Biolabs Co.,Ltd3 Innovent Biologics (Suzhou) Co. Ltd.3 Ipsen2 Nanjing Sanhome Pharmaceutical, Co., Ltd.2 Sun Jing2 Jiangsu Renocell Biotech Company2 Shanghai Junshi Bioscience Co., Ltd.2 Atom Therapeutics Co., Ltd2 Peking University People's Hospital2 HELP Therapeutics Co., Ltd.2 Chongqing Peg-Bio Biopharm Co., Ltd.2 Ruijin Hospital2 Second Xiangya Hospital of Central South University2 Shanghai Pulmonary Hospital, Shanghai, China2 Guangzhou University of Traditional Chinese Medicine2 Abbisko Therapeutics Co, Ltd2 Lepu Biopharma Co., Ltd.2 EMD Serono Research & Development Institute, Inc.2 Genzyme, a Sanofi Company2 The First Affiliated Hospital of Dalian Medical University2 Xiamen University2 Norroy Bioscience Co., LTD2 Astellas Pharma Global Development, Inc.2 Medtronic Cardiac Ablation Solutions2 Shanghai Henlius Biotech2 Edwards Lifesciences2 Guangdong Hengrui Pharmaceutical Co., Ltd2 TCRCure Biopharma Ltd.2 Base Therapeutics (Shanghai) Co., Ltd.2 Peking University Third Hospital2 SyMap Medical (Suzhou), Ltd.2 Yunhe Pharmaceutical (Tianjin) Co., Ltd2 Union Hospital, Tongji Medical College, Huazhong University of Science and Technology2 Peking University2 Zhang longjiang,MD2 Merz North America, Inc.2 Longbio Pharma2 Beijing Anzhen Hospital2 Nanjing Mingzhou Rehabilitation Hospital2 The First Affiliated Hospital of Soochow University2 Cheng Lei2 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.2 Chinese Academy of Medical Sciences, Fuwai Hospital2 Tang-Du Hospital2 Xijing Hospital of Digestive Diseases2 Zhejiang University2 Fudan University2 Second Affiliated Hospital, Zhejiang University, School of Medicine2 Shenzhen Fosun Kairos Biotechnology Co., Ltd.2 Shupei Li2 Du Juan2 Zhejiang Wenda Pharma Technology LTD.2 West China Hospital2 Aragon Pharmaceuticals, Inc.2 Daehwa Pharmaceutical Co., Ltd.1 Ying Gao1 Novlead Inc.1 Zhang Nina1 Otsuka Pharmaceutical Development & Commercialization, Inc.1 Xcovery Holdings, Inc.1 Jiangsu Province Centers for Disease Control and Prevention1 CryoLife, Inc.1 Shanghai AbelZeta Ltd.1 Jianfeng Xie1 Juventas Cell Therapy Ltd.1 Chinese SLE Treatment And Research Group1 Actelion1 Children's Hospital of Chongqing Medical University1 Zhejiang Hisun Pharmaceutical Co. Ltd.1 Chen Lijuan1 Suzhou BlueHorse Therapeutics Co., Ltd.1 Central China Fuwai Hospital of Zhengzhou University1 Lin Liu1 BrightGene Bio-Medical Technology Co., Ltd.1 Guangdong Ruishun Biotech Co., Ltd1 Xiqiao Zhou1 Celcuity Inc1 DK Medical Technology (Suzhou) Co., Ltd.1 Ranok Therapeutics (Hangzhou) Co., Ltd.1 Li-jun Ding1 The Anorectal Center of Nanjing Hospital of Traditional Chinese Medicine1 Min Zhou1 Exelixis1 Xian-Janssen Pharmaceutical Ltd.1 Mabwell (Shanghai) Bioscience Co., Ltd.1 Shanghai Ming Ju Biotechnology Co., Ltd.1 Cascade Pharmaceuticals, Inc1 Aligos Therapeutics1 Yang Zhao1 Central South University1 First Affiliated Hospital of Guangxi Medical University1 Orchestra BioMed, Inc1 Gilead Sciences1 Beijing Friendship Hospital1 Biogen1 Pulnovo Medical, Inc.1 Beeline Medicines Corporation1 Shenzhen Ionova Life Sciences Co., Ltd.1 Reproductive & Genetic Hospital of CITIC-Xiangya1 Yonggui Yuan1 Geriatric Hospital of Nanjing Medical University1 Chinese Medical Association1 Xiamen Ophthalmology Center Affiliated to Xiamen University1 Beijing Pins Medical Co., Ltd1 FrontAce Scientific Co., Ltd1 Betta Pharmaceuticals Co., Ltd.1 Suzhou Municipal Hospital1 Zhongshan Sansure Hygene Biomedicine Co., Ltd.1 Kuirong Jiang1 Shandong University1 Xintian Pharmaceutical1 Mao Jianhua1 Ton-Bridge Medical Tech. Co., Ltd1 Shuangyue Liu1 Fourth Affiliated Hospital of Guangxi Medical University1 Third Military Medical University1 Ye jinjun1 Biosense Webster, Inc.1 Shenzhen Salubris Pharmaceuticals Co., Ltd.1 MedImmune LLC1 JIANG LONGWEI1 yi shen1 DualityBio Inc.1 Nanjing Legend Biotech Co.1 Wenjun Cheng1 Shanghai United Cell Biotechnology Co., Ltd1 Boston Scientific Corporation1 argenx1 Chengdu SciMount Pharmatech Co., Ltd.1 Hangzhou Gensciences Biopharmaceutical Co., Ltd.1 Chunyan Ma1 Shanghai Synvida Biotechnology Co.,Ltd.1 Qurgen Inc.1 Istituto Giannina Gaslini1 Yi Shuhua1 Hansoh BioMedical R&D Company1 Bambusa Therapeutics1 Takeda1 PersonGen BioTherapeutics (Suzhou) Co., Ltd.1 Neurodawn Pharmaceutical Co., Ltd.1 PharmaEssentia1 Karyopharm Therapeutics Inc1 Advenchen Laboratories, LLC1 Johnson & Johnson Medical (Shanghai) Ltd.1 Zenith Epigenetics1 Wen-hong Zhang1 Chongqing Jinsaixing Medical Technology Co., Ltd1 Suzhou HepaThera Biotech Co., Ltd.1 Second Affiliated Hospital of Soochow University1 Eye & ENT Hospital of Fudan University1 Shenzhen Hepalink Pharmaceutical Group Co., Ltd.1 First Teaching Hospital of Tianjin University of Traditional Chinese Medicine1 Guangzhou Patronus Biotech Co., Ltd.1 Jiangsu Chuangyuan Life Science and Technology Co., Ltd.1 Shanghai Minwei Biotechnology Co., Ltd1 Hong Kong Metropolitan University1 Bliss Biopharmaceutical (Hangzhou) Co., Ltd1 Sinovac Biotech Co., Ltd1 Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine1 Geneplus-Beijing Co. Ltd.1 Teligene US1 Ning Jiang, M.D./Ph.D.1 CSPC ZhongQi Pharmaceutical Technology Co., Ltd.1 Zekuan Xu1 Beijing Hospital1 Xiao-Ming Mao1 Hangzhou Highlightll Pharmaceutical Co., Ltd1 Fu Wai Hospital, Beijing, China1 Genentech, Inc.1 WEI XU1 OriCell Therapeutics Co., Ltd.1 Wuxi Hisky Medical Technology Co Ltd1 Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.1 Affiliated Hospital of Nantong University1 Hangzhou Dinova EP Technology Co., Ltd1 Jiangsu Alphamab Biopharmaceuticals Co., Ltd1 Ruitherapeutics Co., LTD1 Sichuan Baili Pharmaceutical Co., Ltd.1 Nanjing Shihejiyin Technology, Inc.1 Children's Cancer Group, China1 Everest Medicines (Beijing) Co., Ltd.1 Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.1 Permed Biomedical Engineering Co., Ltd1 Shanghai Changzheng Hospital1 Xi'an Xintong Pharmaceutical Research Co.,Ltd.1 The Affiliated Hospital of Xuzhou Medical University1 Yang Tao1 Beijing Suncadia Pharmaceuticals Co., Ltd1 Shuanghu Yuan1 Affiliated Hospital of Nanjing University of Chinese Medicine1 Shouyao Holdings (Beijing) Co. LTD1 Hua Huang, MD, PhD1 Beijing QL Biopharmaceutical Co.,Ltd1 Lifetech Scientific (Shenzhen) Co., Ltd.1 Liu Xiufeng1 Jiangsu Hansoh Pharmaceutical Co., Ltd.1 Beijing Tiantan Hospital1 Smith & Nephew, Inc.1 Jin Lu, MD1 InSilico Medicine Hong Kong Limited1 CARsgen Therapeutics Co., Ltd.1 WestVac Biopharma Co., Ltd.1 Pulnovo Medical (Wuxi) Co., Ltd.1 Jiangsu Aosaikang Pharmaceutical Co., Ltd.1 Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany1 Bin Xu1 InnoBM Pharmaceuticals Co., Ltd.1 Shanghai Yizhong Pharmaceutical Co., Ltd.1 Yunlong Wang1 Beijing University of Chinese Medicine1 Changzhou Qianhong Bio-pharma Co., Ltd.1 Chengdu New Radiomedicine Technology Co. LTD.1 Beijing VDJBio Co., LTD.1 Yanbing Yu1 Biotheus Inc.1 Shanghai Auzone Biological Technology Co., Ltd.1 Biotech Pharmaceutical Co., Ltd.1 Allist Pharmaceuticals, Inc.1 Han Ying1 Jiangsu Topcel-KH Pharmaceutical Co., Ltd.1 Ascentawits Pharmaceuticals, Ltd1 Salubris Biotherapeutics Inc1 Nanjing Tianyinshan Hospital1 SUNHO(China)BioPharmaceutical CO., Ltd.1 Suzhou Zelgen Biopharmaceuticals Co.,Ltd1 Suzhou Mednovo Yi Medical Technology Co., Ltd.1 Zhejiang Raygene Pharmaceuticals Co., Ltd1 Alexion Pharmaceuticals, Inc.1 OBI Pharma, Inc1 Shenzhen Core Medical Technology CO.,LTD.1 Vantive Health LLC1 Newish Biotech (Wuxi) Co., Ltd.1 Kezhong Zhang1 Yun Liu,PhD1 ChunBao Li1 Mirati Therapeutics Inc.1 Hutchmed1 Minhu Chen1 GE Healthcare1 Guangzhou Lupeng Pharmaceutical Company LTD.1 Nanfang Hospital, Southern Medical University1 Jacobio Pharmaceuticals Co., Ltd.1 Sinotau Pharmaceutical Group1 Sun Fei1 BioNTech SE1 Yatian Liu1 Haihe Biopharma Co., Ltd.1 Suzhou Genhouse Bio Co., Ltd.1 Eisai Inc.1 Tianjin ConjuStar Biologics Co., Ltd.1 Guangming Lu1 Medtecx Co Ltd.1 Tongji Hospital1 Seagen, a wholly owned subsidiary of Pfizer1 Nuvation Bio Inc.1 Tianjin Medical University Cancer Institute and Hospital1 Genmab1 University Hospital, Basel, Switzerland1 Taiho Oncology, Inc.1 Acepodia Biotech, Inc.1 Beijing Sungen Biomedical Technology Co., Ltd1 Galderma R&D1 Alebund Pharmaceuticals1 R1 Therapeutics1 Yun Chen1 Guangzhou Jiayin Biotech Ltd1 Zhejiang Doer Biologics Co., Ltd.1 Beijing Gene Key Life Technology Co., Ltd1 Zhao Minghui1 Nanjing Bioheng Biotech Co., Ltd.1 Longhua Hospital1 Zhu Weiming1 NYU Langone Health1 The Children's Hospital of Zhejiang University School of Medicine1 Zhang Jianguo1 Jia Wei1 Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1 Akeso1 Prolium Bioscience, Inc1 Shanghai Pharmaceuticals Holding Co., Ltd1 Suzhou Forlong Biotechnology Co., Ltd1 Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University1 Jiangsu Taizhou People's Hospital1 Clear sponsor filter
Target enrolment
to

Trials with a site in Nanjing

1 of 19224 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Zhang Jianguo
Not applicable
86
Beijing, Wuhan, Nanjing, Dalian, Jinan, Shanghai, Tianjin, Hangzhou
2025-11-24
Rows per page Showing 1–1 of 1
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 November 2026. https://priyalifescience.com/clinical-trials-china/city/nanjing

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,224 studies in total at the last sync on 11 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 1 of those studies with a site in Nanjing that also match the filters currently applied.

How many clinical trials are recruiting in Nanjing?

0 of the 1 studies on this page are recruiting new participants as of the 11 Nov 2026, 03:17 UTC sync. A further 1 have not yet opened recruitment, 0 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Nanjing), 1 studies
PhaseStudiesRecruitingShare
Not applicable10100%

Most active sponsors

Lead sponsors with the most studies (Nanjing)
Lead sponsorStudiesRecruiting
Zhang Jianguo10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.